Sleep disorders, other/unspecified

F5_SLEEP_NOS

No definition available.

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — F51.8, F51.9 Cause of death: ICD-10 — F51.8, F51.9 2 out of 7 registries used, show all original rules.	1311
4. Check minimum number of events None	1311
5. Include endpoints None	1311
6. Filter based on genotype QC (FinnGen only)	1311

Control definitions (FinnGen only)

Control exclude: F5_SLEEP

Extra metadata

First used in FinnGen datafreeze: DF5

NAME	F5_SLEEP_NOS
CONTROL_EXCLUDE	F5_SLEEP
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	F51[8-9]
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	F51[8-9]
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Sleep disorders, other/unspecified based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	11736	5917	5770
Only index persons	10393	5350	5043
Unadjusted period prevalence (%)
Whole population	0.16	0.17	0.16
Only index persons	0.19	0.20	0.19
Median age at first event (years)
Whole population	26.58	31.11	21.85
Only index persons	29.83	33.99	25.42

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	1311	875	436
Unadjusted period prevalence (%)	0.26	0.30	0.19
Median age at first event (years)	42.82	41.76	44.95

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
1134: Matched controls
11337

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

F51.9

ICD-10 Finland

Nonorganic sleep disorder, unspecified

1479.6

323.0

998

N06AX11

ATC

mirtazapine; oral

8.6

237.4

755

2139

N05AH04

ATC

quetiapine; oral

9.1

220.6

576

1157

F51.0

ICD-10 Finland

Nonorganic insomnia

10.0

207.7

485

790

IDY03

NOMESCO Finland

Systematic individual therapy, cognitive-behavioural

23.1

187.6

279

158

F51.8

ICD-10 Finland

Other nonorganic sleep disorders

142.6

162.3

170

N05CF01

ATC

zopiclone; oral

4.9

123.8

539

1759

N05BA04

ATC

oxazepam; oral

4.7

110.2

479

1515

N05CF02

ATC

zolpidem; oral

4.8

90.2

363

1021

F32.9

ICD-10 Finland

Depressive episode, unspecified

4.6

82.9

338

952

IAB13

NOMESCO Finland

Psychiatric sleep disorder consultation

+∞

81.2

P06

ICPC

Sleep disturbance

5.5

78.8

263

592

N06AX16

ATC

venlafaxine; oral

4.3

74.3

325

966

F41.9

ICD-10 Finland

Anxiety disorder, unspecified

4.8

74.1

286

750

N05AA02

ATC

levomepromazine; systemic

11.4

70.9

138

136

N05AH03

ATC

olanzapine; systemic

6.6

67.8

188

331

N06AX05

ATC

trazodone; oral

14.0

67.7

119

N06AB10

ATC

escitalopram; oral

3.4

66.9

410

1601

N06AB04

ATC

citalopram; systemic

3.5

60.9

357

1327

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

4.1

58.8

263

778

N05BA01

ATC

diazepam; systemic, rectal

4.2

57.7

247

700

N06AB06

ATC

sertraline; oral

4.2

57.3

250

721

N05CD07

ATC

temazepam; oral

5.4

56.8

187

403

N06AX12

ATC

bupropion; oral

5.1

55.5

192

437

N06AX03

ATC

mianserin; oral

7.8

51.9

125

177

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

6.8

51.1

136

223

N06AA06

ATC

trimipramine; systemic

11.7

50.1

ZY010

NOMESCO Finland

Hospital outpatient

5.6

49.9

155

310

N06AA12

ATC

doxepin; systemic

7.7

49.7

121

174

C07AA05

ATC

propranolol; systemic

3.1

48.9

334

1355

F41.2

ICD-10 Finland

Mixed anxiety and depressive disorder

3.8

48.9

236

735

N03AX16

ATC

pregabalin; oral

3.1

48.8

333

1349

IEY05

NOMESCO Finland

Dedicated profession-specific psychiatric intervention, individual

8.1

48.5

114

155

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

5.6

48.3

150

299

N06AX21

ATC

duloxetine; oral

4.1

47.5

209

599

G47.9

ICD-10 Finland

Sleep disorder, unspecified

10.2

47.1

102

N03AE01

ATC

clonazepam; systemic

6.3

47.0

132

232

N06AB03

ATC

fluoxetine; oral

3.7

46.9

233

741

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

4.4

46.6

184

475

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

3.9

45.5

211

632

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

5.2

45.4

152

330

IEY18

NOMESCO Finland

Psychiatric sleep coaching, individual

443.9

43.5

112

Kela drug reimbursment

Severe psychotic and other severe mental disorders

4.5

42.2

162

405

IAA01

NOMESCO Finland

Assessment of need for psychiatric treatment

8.5

42.0

121

ICZ03

NOMESCO Finland

Participation in compiling a psychiatric treatment plan

6.9

41.3

107

168

N03AG01

ATC

valproic acid; systemic, rectal

5.1

41.0

137

296

F51

ICD-10 Finland

Nonorganic sleep disorders

6.7

39.7

106

173

N05AX08

ATC

risperidone; systemic

4.6

39.1

145

349

Z3231

NOMESCO Finland

Registered nurse

2.5

37.7

366

1792

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

4.2

37.2

152

402

G47.3

ICD-10 Finland

Sleep apnoea

2.9

36.7

266

1091

N06CA01

ATC

amitriptyline and psycholeptics; systemic

4.0

36.1

157

439

N03AX09

ATC

lamotrigine; oral

4.7

34.4

125

294

G25.8

ICD-10 Finland

Other specified extrapyramidal and movement disorders

8.7

34.2

Z2445

NOMESCO Finland

Psychologist

4.8

33.9

119

270

N05AF03

ATC

chlorprothixene; systemic

8.0

33.5

104

F41.1

ICD-10 Finland

Generalized anxiety disorder

4.2

33.1

134

350

ZXE06

NOMESCO Finland

Procedure duration 50 to 59 minutes

4.7

33.0

119

277

R53

ICD-10 Finland

Malaise and fatigue

2.6

33.0

286

1298

N06AX22

ATC

agomelatine; oral

7.2

32.8

122

N04BC05

ATC

pramipexole; oral

5.0

32.4

110

240

N06AA09

ATC

amitriptyline; systemic

3.9

32.1

142

402

N03AX12

ATC

gabapentin; oral

2.9

31.1

211

822

P29

ICPC

Psychological sympt/compl other

3.7

31.0

147

441

F29

ICD-10 Finland

Unspecified nonorganic psychosis

5.0

29.6

100

217

F60.30

ICD-10 Finland

Emotionally unstable personality disorder, impulsive

7.1

28.8

107

ICB01

NOMESCO Finland

Psychiatric treatment plan, standard

5.7

28.8

162

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.1

28.8

476

2913

F10.1

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Harmful use

4.1

28.7

119

317

IGY01

NOMESCO Finland

Accelerated psychiatric treatment contact

7.2

28.4

102

T36

ICD-10 Finland

Poisoning by systemic antibiotics

4.4

28.4

107

260

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

7.4

28.3

A02BC02

ATC

pantoprazole; systemic

2.0

28.3

684

4870

F31.9

ICD-10 Finland

Bipolar affective disorder, unspecified

5.9

28.0

143

Z2446

NOMESCO Finland

Social worker

3.6

27.5

131

393

N05BA12

ATC

alprazolam; oral

3.3

27.3

152

514

F32.1

ICD-10 Finland

Moderate depressive episode

3.6

27.0

128

382

N06AX26

ATC

vortioxetine; oral

3.7

26.8

125

368

G44.2

ICD-10 Finland

Tension-type headache

2.6

26.0

211

909

R51.80

ICD-10 Finland

Headache

2.4

25.2

239

1120

P01

ICPC

Feeling anxious/nervous/tense

2.5

25.2

236

1098

Z71.8

ICD-10 Finland

Other specified counselling

2.2

25.2

336

1852

M79.6

ICD-10 Finland

Pain in limb

2.0

24.8

416

2518

IBZ01

NOMESCO Finland

Profession-specific psychiatric evaluation

7.0

24.4

N05AX12

ATC

aripiprazole; systemic

4.3

24.0

232

G47.0

ICD-10 Finland

Disorders of initiating and maintaining sleep [insomnias]

8.1

23.4

A01

ICPC

Pain general/multiple sites

3.5

23.4

114

348

F32.00

ICD-10 Finland

Mild depressive episode without somatic syndrome

4.2

23.2

235

F60.31

ICD-10 Finland

Emotionally unstable personality disorder, borderline condition

7.0

22.8

IGY02

NOMESCO Finland

Psychiatric monitoring contact

5.7

22.8

124

N02AX02

ATC

tramadol; systemic, rectal

2.0

22.7

427

2681

IFA01

NOMESCO Finland

Psychiatric pharmacotherapy plan, not specified

7.5

22.7

F60.9

ICD-10 Finland

Personality disorder, unspecified

8.2

22.7

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

3.9

22.6

266

P74

ICPC

Anxiety disorder/anxiety state

3.9

22.4

268

N05BA06

ATC

lorazepam; systemic, sublingual

5.0

22.3

153

ZXE13

NOMESCO Finland

Procedure duration 90 to 119 minutes

4.1

22.2

234

P03

ICPC

Feeling depressed

2.5

22.1

187

818

A06AC01

ATC

ispaghula (psylla seeds); oral

2.2

22.0

248

1257

F43.1

ICD-10 Finland

Post-traumatic stress disorder

5.1

21.2

140

Z2221

NOMESCO Finland

Medical doctor

2.0

21.1

336

1968

Z3226

NOMESCO Finland

Physiotherapist

2.3

21.1

222

1088

F33.4

ICD-10 Finland

Recurrent depressive disorder, currently in remission

5.2

20.9

133

N06AB08

ATC

fluvoxamine; oral

5.8

20.8

109

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

20.8

280

1532

G47.2

ICD-10 Finland

Disorders of the sleep-wake schedule

78.3

20.7

N06AB05

ATC

paroxetine; oral

3.3

20.5

108

350

WYA30

NOMESCO Finland

Preparations for expected poor cooperation

3.0

20.5

126

455

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

5.0

20.3

138

P76

ICPC

Depressive disorder

2.9

19.9

126

461

N05AB03

ATC

perphenazine; systemic, rectal

4.9

19.8

142

L17

ICPC

Foot/toe symptom/complaint

2.0

19.5

290

1644

F10.26

ICD-10 Finland

Alcohol dependence periodic alcoholism

9.4

19.5

F31.0

ICD-10 Finland

Bipolar affective disorder, current episode hypomanic

8.0

19.4

ICC04

NOMESCO Finland

Psychiatric treatment plan, permanent discontinuation

5.7

19.4

102

X69

ICD-10 Finland

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

4.1

19.3

203

IGY99

NOMESCO Finland

Other psychiatric treatment contact

5.1

19.2

124

F90.0

ICD-10 Finland

Disturbance of activity and attention

3.8

19.1

236

R4110

NOMESCO Finland

Physiotherapy

2.0

18.9

294

1697

ZXE00

NOMESCO Finland

One hour or less

1.8

18.8

452

3039

F34.1

ICD-10 Finland

Dysthymia

3.9

18.8

213

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

2.0

18.8

283

1610

M54.5

ICD-10 Finland

Low back pain

1.9

18.7

388

2484

A02BC05

ATC

esomeprazole; systemic

1.8

18.6

408

2659

F10.25

ICD-10 Finland

Alcohol dependence continuous use

7.7

18.5

F32

ICD-10 Finland

Depressive episode

3.1

18.5

105

359

N06BA04

ATC

methylphenidate; oral

4.2

18.3

178

N06AG02

ATC

moclobemide; oral

4.4

18.3

159

ZXE02

NOMESCO Finland

Procedure duration 10 to 19 minutes

3.5

18.2

267

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

2.9

18.1

113

411

F33.1

ICD-10 Finland

Recurrent depressive disorder, current episode moderate

4.1

18.1

180

A02BC01

ATC

omeprazole; systemic

2.0

18.0

274

1563

R41.8

ICD-10 Finland

Other and unspecified symptoms and signs involving cognitive functions and awareness

3.4

17.9

287

F51.2

ICD-10 Finland

Nonorganic disorder of the sleep-wake schedule

23.2

17.8

Z03.2

ICD-10 Finland

Observation for suspected mental and behavioural disorders

6.1

17.7

C07AB07

ATC

bisoprolol; oral

1.8

17.5

363

2308

F31.7

ICD-10 Finland

Bipolar affective disorder, currently in remission

5.6

17.5

F31.4

ICD-10 Finland

Bipolar affective disorder, current episode severe depression without psychotic symptoms

6.6

17.5

Z76.0

ICD-10 Finland

Issue of repeat prescription

2.2

17.4

202

1026

ZXE10

NOMESCO Finland

More than one and less than three hours

1.8

17.3

373

2403

N05BE01

ATC

buspirone; oral

4.6

17.3

135

N05AN01

ATC

lithium; oral

4.9

17.2

122

IBA03

NOMESCO Finland

Psychotherapy evaluation

8.2

17.1

N07BB01

ATC

disulfiram; oral

3.7

17.0

216

R5140

NOMESCO Finland

Monitoring the use of the aid

2.7

16.8

117

456

F31.6

ICD-10 Finland

Bipolar affective disorder, current episode mixed

6.8

16.7

F61.0

ICD-10 Finland

Mixed personality disorders

5.3

16.5

XF400

NOMESCO Finland

ECG with 12 standard connections

2.3

16.5

163

768

L01

ICPC

Neck symptom/complaint

2.2

16.5

185

925

IBA04

NOMESCO Finland

Extensive initial psychiatric evaluation

5.7

16.4

F60.3

ICD-10 Finland

Emotionally unstable personality disorder

7.3

16.4

A04

ICPC

Weakness/tiredness general

2.2

16.2

181

900

F10.29

ICD-10 Finland

Addiction caused by alcohol UNS

5.5

16.2

J45.9

ICD-10 Finland

Asthma, unspecified

2.1

16.0

206

1090

AA1BG

NOMESCO Finland

Standard MRI examination of brain with high intensity magnet

2.7

16.0

113

444

XA800

NOMESCO Finland

Neuropsychological investigation

3.6

16.0

212

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

2.0

15.8

223

1226

F32.3

ICD-10 Finland

Severe depressive episode with psychotic symptoms

5.3

15.7

L03

ICPC

Low back symptom/complaint

1.9

15.7

284

1713

F99

ICD-10 Finland

Mental disorder, not otherwise specified

4.9

15.6

108

AA1AD

NOMESCO Finland

CT of head and brain

2.1

15.6

203

1080

M25.5

ICD-10 Finland

Pain in joint

1.8

15.5

325

2057

M03BX02

ATC

tizanidine; oral

1.7

15.4

662

5178

N03AX11

ATC

topiramate; oral

4.7

15.3

115

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.7

15.2

474

3385

F31.30

ICD-10 Finland

Bipolar disorder Depressive episode without somatic syndrome

5.1

15.0

F39

ICD-10 Finland

Unspecified mood [affective] disorder

4.7

15.0

113

R06.0

ICD-10 Finland

Dyspnoea

1.9

14.9

239

1375

ZXE05

NOMESCO Finland

Procedure duration 40 to 49 minutes

3.1

14.9

285

P16

ICPC

Acute alcohol abuse

6.8

14.9

ZXY51

NOMESCO Finland

2-person team, doctor-nurse

5.2

14.8

IAB01

NOMESCO Finland

Psychiatric pharmacotherapy consultation

13.4

14.7

Z03

ICD-10 Finland

Medical observation and evaluation for suspected diseases and conditions, ruled out

2.6

14.7

109

442

P99

ICPC

Psychological disorders other

3.9

14.6

159

F51.3

ICD-10 Finland

Sleepwalking [somnambulism]

+∞

14.6

X59

ICD-10 Finland

Exposure to unspecified factor

2.0

14.4

221

1250

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.9

14.2

320

SPAT1240

SPAT

Therapeutic discussion

2.1

14.1

177

925

F33.30

ICD-10 Finland

Recurrent depression, severe episode without somatic syndrome

9.5

14.0

ZXE15

NOMESCO Finland

Procedure duration 120 to 149 minutes

4.3

13.9

122

N05AB01

ATC

dixyrazine; systemic

12.9

13.9

R07.4

ICD-10 Finland

Chest pain, unspecified

1.9

13.9

241

1422

F31.8

ICD-10 Finland

Other bipolar affective disorders

4.9

13.9

N05BA02

ATC

chlordiazepoxide; systemic

5.9

13.8

R00.2

ICD-10 Finland

Palpitations

2.6

13.8

103

418

N05CD02

ATC

nitrazepam; oral

9.8

13.7

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.9

13.6

310

A06AD11

ATC

lactulose; oral

2.4

13.6

119

524

D11

ICPC

Diarrhoea

2.1

13.6

163

834

R10.1

ICD-10 Finland

Pain localized to upper abdomen

2.0

13.6

188

1021

SAA01

NOMESCO Finland

Simple examination of mouth

1.7

13.4

820

6921

F10.30

ICD-10 Finland

Withdrawal symptoms caused by alcohol uncomplicated

8.2

13.3

WX110

NOMESCO Finland

Local anesthesy

1.6

13.3

799

6702

IBA01

NOMESCO Finland

Diagnostic and symptom-mapping evaluation

5.3

13.3

ICB03

NOMESCO Finland

Psychiatric treatment plan, monitoring

5.3

13.3

ZYC01

NOMESCO Finland

Remote contact by phone

3.3

13.2

212

IBB02

NOMESCO Finland

Psychiatric evaluation of working capacity and rehabilitation

10.2

13.0

N05AD01

ATC

haloperidol; systemic

4.8

13.0

ZY000

NOMESCO Finland

Hospital inpatient

6.0

12.9

F60.5

ICD-10 Finland

Anankastic personality disorder

6.4

12.8

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.8

12.8

277

1757

M79.1

ICD-10 Finland

Myalgia

2.1

12.7

159

831

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

2.5

12.7

102

431

F13.29

ICD-10 Finland

Addiction caused by sedative and hypnotic UNS

15.6

12.6

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

6.0

12.6

K59.0

ICD-10 Finland

Constipation

3.2

12.4

217

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.9

12.4

192

1089

D01

ICPC

Abdominal pain/cramps general

2.0

12.3

158

830

F10.20

ICD-10 Finland

Alcohol dependence currently independent

4.9

12.3

N02AJ06

ATC

codeine and paracetamol; systemic

1.6

12.2

400

2853

F31.1

ICD-10 Finland

Bipolar affective disorder, current episode manic without psychotic symptoms

7.1

12.1

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

2.1

12.1

148

763

R05

ICPC

Cough

1.8

12.0

260

1644

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.6

12.0

364

2537

N05AF01

ATC

flupentixol; systemic

7.3

12.0

IFB01

NOMESCO Finland

Electroconvulsive Therapy (ECT)

10.2

12.0

N05AA01

ATC

chlorpromazine; systemic, rectal

6.9

12.0

ZXD10

NOMESCO Finland

Scheduled procedure

1.6

11.9

382

2700

F41.09

ICD-10 Finland

UNS Panic Syndrome

3.2

11.8

202

P15

ICPC

Chronic alcohol abuse

3.9

11.8

123

F41.3

ICD-10 Finland

Other mixed anxiety disorders

5.1

11.8

R74

ICPC

Upper respiratory infection acute

1.6

11.7

404

2908

D12

ICPC

Constipation

4.2

11.7

109

R33

ICD-10 Finland

Retention of urine

3.4

11.7

176

M54.9

ICD-10 Finland

Dorsalgia, unspecified

2.1

11.7

133

666

F19.1

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, harmful use

7.8

11.7

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.6

11.7

429

3139

M79.2

ICD-10 Finland

Neuralgia and neuritis, unspecified

4.9

11.5

ICB02

NOMESCO Finland

Psychiatric treatment plan, extended/prolonged

6.4

11.4

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.5

11.4

597

4745

F13.25

ICD-10 Finland

Addiction caused by sedative and hypnotic continuous use

12.0

11.3

AA400

NOMESCO Finland

Electroconvulsive therapy

8.4

11.3

F22.0

ICD-10 Finland

Delusional disorder

7.4

11.3

H04.10

ICD-10 Finland

Dry eye syndrome

2.4

11.2

420

F20.9

ICD-10 Finland

Schizophrenia, unspecified

4.5

11.1

R42

ICD-10 Finland

Dizziness and giddiness

1.8

11.0

193

1138

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.5

11.0

567

4476

F31.3

ICD-10 Finland

Bipolar affective disorder, current episode mild or moderate depression

7.5

11.0

F40.1

ICD-10 Finland

Social phobias

3.4

10.9

158

H02AB06

ATC

prednisolone; systemic

1.5

10.7

442

3309

A29

ICPC

General symptom/complaint other

2.2

10.7

111

534

M01AE02

ATC

naproxen; oral, rectal

1.5

10.7

630

5116

ZXD31

NOMESCO Finland

Major difficulties in performing procedure

3.3

10.7

161

G47.8

ICD-10 Finland

Other sleep disorders

8.1

10.6

F21

ICD-10 Finland

Schizotypal disorder

11.3

10.6

R5110

NOMESCO Finland

Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it

2.2

10.6

114

557

L08

ICPC

Shoulder symptom/complaint

1.8

10.5

181

1060

S21

ICPC

Skin texture symptom/complaint

2.1

10.5

127

651

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

10.4

273

1818

F42.1

ICD-10 Finland

Predominantly compulsive acts [obsessional rituals]

7.8

10.4

F51.5

ICD-10 Finland

Nightmares

32.8

10.3

F31.20

ICD-10 Finland

Bipolar disorder, manic episode with mood-congruent psychotic symptoms

6.1

10.3

Z53.2

ICD-10 Finland

Procedure not carried out because of patient's decision for other and unspecified reasons

5.6

10.3

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

2.7

10.3

271

R03AC02

ATC

salbutamol; inhalant

1.5

10.3

570

4546

N17

ICPC

Vertigo/dizziness

2.2

10.3

112

548

F13.1

ICD-10 Finland

Mental and behavioural disorders due to use of sedatives or hypnotics, harmful use

10.7

10.3

WX002

NOMESCO Finland

Sedation and analgesia

1.8

10.3

175

1019

SPAT1307

SPAT

Psychosocial counselling and guidance

2.1

10.3

117

587

R06.5

ICD-10 Finland

Mouth breathing

2.3

10.2

100

466

M54.4

ICD-10 Finland

Lumbago with sciatica

1.8

10.2

175

1024

TPH04

NOMESCO Finland

Cathetrisation of vein

1.8

10.2

194

1175

A02BC03

ATC

lansoprazole; oral

1.7

10.2

240

1550

N02BE01

ATC

paracetamol; systemic, rectal

1.6

10.1

887

7841

WX780

NOMESCO Finland

Remote monitoring CPAP

3.4

10.1

146

G43.9

ICD-10 Finland

Migraine, unspecified

2.3

10.1

438

F13.22

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent but uses substitute intermittent medication

14.7

10.0

H53.1

ICD-10 Finland

Subjective visual disturbances

2.6

10.0

300

F51.4

ICD-10 Finland

Sleep terrors [night terrors]

40.4

10.0

F32.8

ICD-10 Finland

Other depressive episodes

4.4

9.9

S29

ICPC

Skin symptom/complaint other

1.8

9.9

169

985

R02

ICPC

Shortness of breath/dyspnoea

2.0

9.9

123

639

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.0

9.9

136

733

S06.0

ICD-10 Finland

Concussion

2.0

9.9

122

630

R52.2

ICD-10 Finland

Other chronic pain

3.5

9.9

133

M01AE03

ATC

ketoprofen; systemic, rectal

1.6

9.8

329

2330

R56.8

ICD-10 Finland

Other and unspecified convulsions

2.7

9.8

254

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.5

9.8

537

4260

N05AE04

ATC

ziprasidone; systemic

7.9

9.6

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.6

9.6

339

2429

F25.9

ICD-10 Finland

Schizoaffective disorder, unspecified

5.5

9.5

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.8

9.5

190

1163

N01

ICPC

Headache

1.8

9.5

182

1100

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.8

9.5

174

1040

R4160

NOMESCO Finland

Other therapy enhancing rehabilitation

3.9

9.5

WX723

NOMESCO Finland

CPAP therapy

3.5

9.4

127

R5599

NOMESCO Finland

Other rehabilitation service

3.7

9.4

112

K30

ICD-10 Finland

Functional dyspepsia

2.1

9.4

108

543

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

1.9

9.4

138

765

R52.9

ICD-10 Finland

Pain, unspecified

2.2

9.4

443

KMAK

NOMESCO Finland

1.5

9.3

575

4652

F41.8

ICD-10 Finland

Other specified anxiety disorders

3.0

9.3

182

F33.00

ICD-10 Finland

Recurrent depression, mild episode without somatic syndrome

4.1

9.3

G43.3

ICD-10 Finland

Complicated migraine

4.3

9.2

UJF32

NOMESCO Finland

Coloscopy

1.7

9.2

203

1282

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.8

9.2

184

1129

N06AA10

ATC

nortriptyline; systemic

4.6

9.1

H93.1

ICD-10 Finland

Tinnitus

2.6

9.1

266

F31.31

ICD-10 Finland

Bipolar disorder depressive episode with somatic syndrome

8.4

9.1

H03AA01

ATC

levothyroxine sodium; systemic

1.7

9.0

222

1447

F10.40

ICD-10 Finland

Withdrawal symptoms and delirium caused by alcohol without seizures

7.5

8.9

F31

ICD-10 Finland

Bipolar affective disorder

4.7

8.9

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

2.1

8.9

469

P01AB01

ATC

metronidazole; oral, rectal

1.5

8.9

396

2983

E66.8

ICD-10 Finland

Other obesity

2.5

8.9

276

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.0

8.8

112

584

F90.9

ICD-10 Finland

Hyperkinetic disorder, unspecified

8.7

8.8

F10.9

ICD-10 Finland

Mental and behavioural disorders due to use of alcohol, Unspecified mental and behavioural disorder

9.6

8.8

TKC20

NOMESCO Finland

Catheterisation of bladder

2.7

8.8

226

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

2.4

8.8

317

F50.9

ICD-10 Finland

Eating disorder, unspecified

4.4

8.8

M79.7

ICD-10 Finland

Fibromyalgia

3.1

8.7

158

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

2.1

8.7

481

N06AA04

ATC

clomipramine; systemic

4.9

8.7

L28

ICPC

Limited function/disability (L)

2.0

8.7

119

639

IEY01

NOMESCO Finland

Psychoeducation, individual

6.7

8.7

M01AG02

ATC

tolfenamic acid; oral, rectal

1.7

8.7

170

1038

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

2.1

8.6

448

WZA90

NOMESCO Finland

Other doctors statement

1.6

8.6

254

1735

L12

ICPC

Hand/finger symptom/complaint

1.8

8.6

158

943

S18

ICPC

Laceration/cut

1.5

8.6

362

2689

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

2.2

8.6

415

F13.20

ICD-10 Finland

Addiction relationship caused by sedatives and hypnotics currently independent

16.4

8.6

R11

ICD-10 Finland

Nausea and vomiting

2.2

8.5

431

331

Kela drug reimbursment

Atomoxetine, dexamphetamine, guanfacine and lisdexamphetamine

6.5

8.5

F43.9

ICD-10 Finland

Reaction to severe stress, unspecified

3.2

8.5

133

F22.9

ICD-10 Finland

Persistent delusional disorder, unspecified

27.7

8.5

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.6

8.5

233

L84

ICPC

Back syndrome without radiat pain

2.8

8.5

202

F45.8

ICD-10 Finland

Other somatoform disorders

2.1

8.4

487

K02.1

ICD-10 Finland

Caries of dentine

1.5

8.4

665

5605

F25.00

ICD-10 Finland

Schizoaffective syndrome, manic type with only simultaneous bipolar and schizophrenic symptoms

6.8

8.4

SAA03

NOMESCO Finland

Extended examination of mouth

1.5

8.4

457

3582

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

2.2

8.4

405

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.9

8.3

133

755

X44

ICD-10 Finland

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

4.3

8.3

M03BC01

ATC

orphenadrine (citrate); systemic

1.6

8.3

253

1743

L29

ICPC

Musculoskeletal sympt/complt other

2.2

8.2

366

N06AX17

ATC

milnacipran; oral

5.4

8.2

R41.0

ICD-10 Finland

Disorientation, unspecified

4.4

8.2

R35

ICD-10 Finland

Polyuria

2.7

8.1

211

J45

ICD-10 Finland

Asthma

2.0

8.1

103

538

F13.24

ICD-10 Finland

Addiction relationship caused by sedative and hypnotic active addiction

11.8

8.1

F10.00

ICD-10 Finland

Alcohol-related acute intoxication uncomplicated

3.8

8.1

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

2.3

8.0

320

R01AD09

ATC

mometasone; nasal

1.4

8.0

488

3902

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.5

8.0

320

2347

K07.60

ICD-10 Finland

Snapping jaw

2.4

8.0

292

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.6

7.9

256

1786

R12

ICD-10 Finland

Heartburn

2.2

7.9

348

C07AB02

ATC

metoprolol; systemic

1.8

7.9

133

774

R61.9

ICD-10 Finland

Hyperhidrosis, unspecified

6.1

7.9

Z3229

NOMESCO Finland

Other healthcare associate professional

2.1

7.9

397

P27

ICPC

Fear of mental disorder

4.7

7.8

F10.24

ICD-10 Finland

Alcohol depence active use

4.2

7.8

X15

ICPC

Vaginal symptom/complaint other

2.5

7.8

231

F50.2

ICD-10 Finland

Bulimia nervosa

7.0

7.8

Z01.7

ICD-10 Finland

Laboratory examination

1.9

7.8

116

646

A02BA04

ATC

nizatidine; systemic

2.5

7.8

250

ZXA10

NOMESCO Finland

Bilateral

1.7

7.7

163

1014

F10.09

ICD-10 Finland

Alcohol intoxication UNS

3.5

7.7

ZXY01

NOMESCO Finland

Chief Physician, Head of Department or Deputy Chief Physician

5.3

7.7

A97

ICPC

No disease

1.7

7.7

166

1040

N06BA12

ATC

lisdexamfetamine; oral

7.5

7.7

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.8

7.7

124

708

D02

ICPC

Abdominal pain epigastric

2.3

7.6

306

K08.80

ICD-10 Finland

Toothache NOS

2.0

7.6

479

SPAT1389

SPAT

Visit based on need for special support

2.5

7.6

228

N06AX18

ATC

reboxetine; oral

5.0

7.6

R03AK07

ATC

formoterol and budesonide; inhalant

1.6

7.6

192

1256

SPAT1309

SPAT

Guidance related to psychoactive substances / risk behaviour

2.9

7.6

162

F20.00

ICD-10 Finland

Paranoid schizophrenia continuous

3.7

7.6

Q79.6

ICD-10 Finland

Ehlers-Danlos syndrome

11.9

7.6

EBA00

NOMESCO Finland

Extraction of tooth

1.5

7.6

350

2638

IBA02

NOMESCO Finland

Evaluation of need for psychiatric rehabilitation

6.2

7.6

IER01

NOMESCO Finland

Psychoeducation, group

6.2

7.6

B18.2

ICD-10 Finland

Chronic viral hepatitis C

4.7

7.5

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.9

7.5

119

674

Z71

ICD-10 Finland

Persons encountering health services for other counselling and medical advice, not elsewhere classified

2.9

7.5

150

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.6

7.5

203

1354

Z01.8

ICD-10 Finland

Other specified special examinations

1.6

7.5

204

1360

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

2.0

7.5

449

L15

ICPC

Knee symptom/complaint

1.6

7.4

195

1289

N05AD03

ATC

melperone; systemic

6.0

7.4

N05AC02

ATC

thioridazine; oral

3.7

7.4

SXA20

NOMESCO Finland

Local application of medicine to mouth

2.1

7.4

388

R60.0

ICD-10 Finland

Localized oedema

2.0

7.3

445

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.4

7.3

593

4967

D09

ICPC

Nausea

2.2

7.3

355

L29.9

ICD-10 Finland

Pruritus, unspecified

4.0

7.3

R21

ICPC

Throat symptom/complaint

1.5

7.2

289

2109

SPAT1260

SPAT

Consultation of another employee

1.7

7.2

169

1080

Z72.1

ICD-10 Finland

Alcohol use

4.7

7.2

I95.1

ICD-10 Finland

Orthostatic hypotension

4.7

7.2

A02BA02

ATC

ranitidine; systemic

1.7

7.2

142

865

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.8

7.2

127

749

F33

ICD-10 Finland

Recurrent depressive disorder

3.2

7.2

111

G56.2

ICD-10 Finland

Lesion of ulnar nerve

3.0

7.2

128

Z50.1

ICD-10 Finland

Other physical therapy

2.6

7.1

200

L02

ICPC

Back symptom/complaint

1.9

7.1

109

615

F10.39

ICD-10 Finland

Withdrawal symptoms caused by alcohol UNS

5.3

7.1

L18

ICPC

Muscle pain

2.7

7.1

182

AA40B

NOMESCO Finland

12.1

7.1

J45.1

ICD-10 Finland

Nonallergic asthma

2.1

7.0

347

K04

ICPC

Palpitations/awareness of heart

2.5

7.0

212

P25

ICPC

Phase of life problem adult

2.4

7.0

240

K85

ICPC

Elevated blood pressure

1.9

7.0

528

N39.4

ICD-10 Finland

Other specified urinary incontinence

2.3

7.0

260

M03BC51

ATC

orphenadrine, combinations; systemic

1.5

7.0

269

1946

J01DB01

ATC

cefalexin; oral

1.5

6.9

876

7920

N89

ICPC

Migraine

2.4

6.9

254

J01CA04

ATC

amoxicillin; systemic

1.5

6.9

932

8536

WX290

NOMESCO Finland

Other blockade of nerve

1.4

6.9

536

4437

J01FA06

ATC

roxithromycin; oral

1.4

6.9

374

2901

J01DA01

ATC

[U] cefalexin; systemic

1.4

6.9

635

5416

SCA01

NOMESCO Finland

Simple analysis and advice of nutrition with regard to dentistry

1.4

6.9

370

2864

ZXD05

NOMESCO Finland

Urgent procedure

1.5

6.8

308

2299

M01AH05

ATC

etoricoxib; oral

1.4

6.8

561

4690

N02CC04

ATC

rizatriptan; oral

2.1

6.8

351

N04AA02

ATC

biperiden; systemic

3.9

6.8

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.8

6.8

106

601

Z73.0

ICD-10 Finland

Burn-out

2.8

6.8

151

J01FF01

ATC

clindamycin; systemic

1.5

6.8

247

1765

ZYY01

NOMESCO Finland

Contact between professionals

16.8

6.7

R20.2

ICD-10 Finland

Paraesthesia of skin

2.1

6.7

380

A99

ICPC

Disease/condition unspecnature/site

2.1

6.7

380

3007

Kela drug reimbursment

Erenumab and fremanezumab

4.7

6.7

F60.6

ICD-10 Finland

Anxious [avoidant] personality disorder

7.2

6.7

G04BD12

ATC

mirabegron; oral

2.2

6.7

285

R03AC03

ATC

terbutaline; inhalant

1.7

6.7

144

900

T74.1

ICD-10 Finland

Physical abuse

3.2

6.7

106

C09CA06

ATC

candesartan; oral

1.6

6.7

170

1115

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

6.7

186

1248

K59.1

ICD-10 Finland

Functional diarrhoea

2.4

6.7

225

F43.8

ICD-10 Finland

Other reactions to severe stress

3.1

6.7

112

ZXA00

NOMESCO Finland

Right side

1.5

6.7

211

1461

ZXD20

NOMESCO Finland

Day surgery

1.7

6.6

129

783

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.5

6.6

298

2222

F32.0

ICD-10 Finland

Mild depressive episode

2.8

6.6

147

WX408

NOMESCO Finland

General anesthesy, balanced

1.5

6.6

252

1816

Z73.8

ICD-10 Finland

Other problems related to life-management difficulty

5.5

6.6

N05AH02

ATC

clozapine; systemic

3.3

6.6

A11

ICPC

Chest pain NOS

2.2

6.6

301

ZXE01

NOMESCO Finland

Procedure duration 0 to 9 minutes

3.8

6.6

SHA02

NOMESCO Finland

Correction of physiology of bite - basic therapy visit

2.0

6.6

429

IAB11

NOMESCO Finland

Psychiatric mood consultation

12.3

6.6

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.9

6.6

555

ZYD01

NOMESCO Finland

Emergency clinic

8.8

6.6

F19.9

ICD-10 Finland

Mental and behavioural disorders due to multiple drug use and use of other psychoactive substances, unspecified mental and behavioural disorder

10.1

6.5

R51.81

ICD-10 Finland

Facial pain NOS

3.3

6.5

C03CA01

ATC

furosemide; systemic

1.7

6.5

144

909

A06AC51

ATC

ispaghula, combinations; systemic

2.5

6.5

192

ZXY60

NOMESCO Finland

2-person team, nurses

5.7

6.5

G04CA02

ATC

tamsulosin; oral

1.8

6.5

109

635

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

2.1

6.4

360

C07AB12

ATC

nebivolol; oral

3.5

6.4

R03DC03

ATC

montelukast; oral

1.6

6.4

170

1123

ICC01

NOMESCO Finland

Psychiatric treatment plan, transfer to psychiatric outpatient clinic

7.4

6.4

UJF30

NOMESCO Finland

Ileoscopy through colon

1.9

6.4

476

K92.0

ICD-10 Finland

Haematemesis

3.7

6.4

P18

ICPC

Medication abuse

6.6

6.3

LC2AE

NOMESCO Finland

Ultrasound examination of uterus and parametria

1.7

6.3

123

747

WYA10

NOMESCO Finland

First aid or other corresponding healthcare contact

1.9

6.3

514

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

6.3

426

3422

Z72.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

429

1630

3.43

88.09

2.2

1.7

1.5

1.4

3.09

393

1484

(3021960) Folate [Moles/volume] in Serum or Plasma

434

1854

3.00

70.76

1.6

1.4

nmol/l

21.0

20.6

0.21

395

1613

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

636

3371

2.72

68.14

2.1

1.8

pmol/l

98.4

96.9

0.37

328

1802

(3015377) Calcium [Moles/volume] in Serum or Plasma

569

2940

2.65

62.93

2.8

3.1

mmol/l

2.4

0.19

518

2639

(3028707) Methadone [Presence] in Urine by Screen method

154

374

4.53

58.80

2.8

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

700

4204

2.43

53.54

6.5

6.2

mmol/l

1.2

0.97

592

3559

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

644

3778

2.38

51.26

6.4

5.7

mmol/l

1.2

0.12

590

3456

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

683

4121

2.37

50.82

2.6

2.3

nmol/l

73.8

73.5

0.12

636

3793

(3011288) Drugs identified in Urine by Screen method

190

598

3.55

50.27

3.2

3.0

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

298

1233

2.83

49.40

2.7

2.3

g/l

2.4

0.05

274

1128

(3018418) pH of Serum or Plasma

479

2503

2.44

49.06

4.5

3.7

7.4

0.17

479

(3022948) Iron [Moles/volume] in Serum or Plasma

312

1330

2.77

48.79

2.7

2.3

umol/l

15.2

14.0

1.97

289

1222

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

597

3482

2.31

47.01

3.8

3.2

u/l

28.9

30.6

0.70

570

3319

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

1101

8415

2.93

46.25

5.4

3.9

pmol/l

14.5

0.16

1024

7761

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

273

1126

2.80

45.17

2.8

2.4

25.2

23.6

1.01

240

971

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

999

7430

2.45

41.69

8.0

6.9

u/l

73.8

75.6

0.92

949

6992

(3013707) Erythrocyte sedimentation rate by Westergren method

994

7431

2.40

40.08

4.4

3.8

mm/h

9.1

9.7

1.09

930

6908

(42870588) Differential panel, method unspecified - Blood

555

3306

2.18

39.71

5.6

6.0

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

190

690

3.05

39.35

2.5

2.1

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

599

3727

2.12

37.76

4.8

4.7

g/l

36.8

36.6

0.26

554

3477

(3001122) Ferritin [Mass/volume] in Serum or Plasma

760

5205

2.09

36.65

3.8

2.8

ug/l

77.4

86.5

1.32

714

4893

(3016879) Cocaine [Presence] in Urine

205

812

2.81

36.10

2.6

2.2

—

(3018095) Leukocytes [#/volume] in Urine

550

3378

2.08

35.23

4.0

3.3

e6/l

45.1

88.0

1.66

387

2251

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

985

7521

2.25

34.80

4.3

2.9

u/l

37.4

39.3

0.58

932

7172

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

1184

9847

3.09

34.27

6.7

4.5

mu/l

1.7

2.0

1.17

1131

9218

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

434

2475

2.13

33.52

2.4

2.1

u/l

239.2

236.9

0.01

405

2355

(3026782) Osmolality of Urine

337

1745

2.25

33.16

2.7

2.5

mosm/kgh2o

526.7

556.6

1.34

279

1503

(3002582) Erythrocytes [#/volume] in Urine

463

2722

2.08

32.86

3.4

2.9

e6/l

26.1

63.0

2.02

357

2061

(3000764) Benzodiazepines [Presence] in Urine

209

876

2.65

32.79

2.6

2.1

—

(3028300) Cannabinoids [Presence] in Urine

210

887

2.63

32.42

2.5

2.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

216

926

2.60

32.34

2.7

2.3

u/l

33.0

93.8

0.60

181

775

(3027008) Opiates [Presence] in Urine

209

884

2.62

32.16

2.5

2.1

—

(3044889) 12 lead EKG panel

878

6524

2.05

31.70

3.8

3.1

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

694

4783

1.96

30.76

5.3

5.8

umol/l

10.1

10.7

0.77

658

4516

(3013650) Neutrophils [#/volume] in Blood by Automated count

821

5994

1.99

30.69

9.3

8.7

e9/l

4.2

4.0

1.50

712

5272

(3030467) Casts [#/volume] in Urine by Automated count

425

2478

2.06

30.39

3.3

2.8

e6/l

0.2

0.4

2.08

327

1833

(3027944) Amphetamines [Presence] in Urine

203

873

2.57

30.08

2.6

2.1

—

(3019309) Folate [Moles/volume] in Red Blood Cells

269

1315

2.32

30.05

1.8

1.7

nmol/l

1142.1

1169.0

0.16

212

1025

(36304419) Bacteria [Presence] in Urine

422

2463

2.05

30.03

3.3

2.7

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

1163

9750

2.71

29.90

4.6

3.7

mmol/l

5.7

5.8

0.33

1080

9055

(3000850) Epithelial cells [#/volume] in Urine

344

1873

2.13

29.38

2.5

2.4

e6/l

8.9

7.5

0.55

292

1649

(40758558) Short blood count panel - Blood

433

2572

2.02

29.19

6.9

6.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

218

986

2.45

28.95

2.1

2.0

nmol/l

371.3

375.9

0.12

194

911

(3001604) Monocytes [#/volume] in Blood

728

5186

1.91

28.30

6.5

6.0

e9/l

0.6

0.5

1.17

627

4573

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

122

5.11

28.13

1.6

2.3

—

(3013115) Eosinophils [#/volume] in Blood

748

5388

1.90

27.96

7.1

6.3

e9/l

0.2

0.37

659

4824

(3007164) IgA [Mass/volume] in Serum or Plasma

411

2429

2.01

27.88

1.6

1.4

g/l

2.2

0.18

216

1536

(3006315) Basophils [#/volume] in Blood

728

5208

1.89

27.70

6.5

6.0

e9/l

0.0

0.47

630

4589

(3021589) Normoblasts [#/volume] in Blood

668

4654

1.89

27.54

10.1

8.4

e9/l

0.0

0.10

537

3843

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

398

2342

2.00

27.22

2.4

2.1

mg/l

2.6

2.8

0.94

324

2016

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

505

3223

1.92

27.20

3.4

3.0

—

(3002030) Lymphocytes/100 leukocytes in Blood

717

5129

1.88

27.02

6.4

6.0

29.1

29.3

0.20

681

4820

(3019198) Lymphocytes [#/volume] in Blood

746

5406

1.88

26.97

6.5

6.0

e9/l

2.0

0.96

665

4851

(3006504) Eosinophils/100 leukocytes in Blood

690

4891

1.87

26.61

6.4

6.0

2.8

0.02

650

4571

(3022096) Basophils/100 leukocytes in Blood

670

4706

1.87

26.60

6.4

6.1

0.7

0.03

632

4413

(44816559) Phosphatidylethanol [Mass/volume] in Blood

266

3.60

26.56

1.6

1.2

—

(3019069) Monocytes/100 leukocytes in Blood

692

4916

1.86

26.44

6.7

6.2

8.0

8.2

1.02

656

4639

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

140

533

2.82

26.25

1.7

1.8

mg/l

3.3

3.6

0.19

126

357

(3018010) Neutrophils/100 leukocytes in Blood

707

5067

1.86

26.16

6.3

5.8

56.4

56.5

0.06

671

4779

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

455

2841

1.92

25.91

1.5

1.3

u/ml

1.3

1.6

0.33

102

783

(3009466) Valproate [Moles/volume] in Serum or Plasma

153

4.42

25.56

5.9

umol/l

377.6

370.7

0.12

138

(3019550) Sodium [Moles/volume] in Serum or Plasma

1203

10436

2.85

25.53

18.0

11.6

mmol/l

139.5

139.6

1.17

1176

10147

(3023103) Potassium [Moles/volume] in Serum or Plasma

1204

10476

2.83

24.88

18.2

11.7

mmol/l

3.9

2.26

1174

10169

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

274

1456

2.11

24.43

2.9

2.6

mmol/l

2.4

0.07

248

1276

(3033658) Prothrombin time (PT) actual/Normal

389

2367

1.91

23.54

4.7

3.8

96.4

94.5

0.91

376

2295

(1002224) Polysomnography panel

129

502

2.74

23.14

1.1

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

398

2489

1.86

21.85

1.6

mmol/l

1.5

1.4

0.52

345

2162

(3013826) Glucose [Moles/volume] in Serum or Plasma

728

5450

1.76

21.56

5.3

4.5

mmol/l

6.3

6.5

0.90

678

4968

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

252

1376

2.03

20.57

3.0

2.6

e6/l

4.5

3.1

0.78

130

712

(3048689) Calprotectin [Mass/mass] in Stool

281

1604

1.96

20.17

2.3

2.6

ug/g

80.1

119.7

3.15

228

1274

(3002032) Base excess in Venous blood by calculation

161

747

2.32

19.84

5.6

3.7

mmol/l

1.5

1.8

0.50

132

606

(3000494) Fungus identified in Specimen by Culture

220

1158

2.08

19.79

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

157

722

2.33

19.74

2.4

2.1

nmol/l

13.5

12.8

0.33

134

655

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

270

1533

1.96

19.64

3.8

3.3

ng/l

403.4

563.0

0.26

161

976

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

210

1096

2.09

19.29

2.2

2.7

umol/l

8.1

6.9

0.29

169

943

(3009508) Creatinine [Moles/volume] in Urine

417

2732

1.77

19.17

3.3

mmol/l

8.4

8.1

0.31

365

2371

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

259

1462

1.96

19.12

2.9

2.4

e6/l

1.4

1.1

0.52

137

790

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

153

706

2.32

19.07

3.5

3.3

pmol/l

4.5

4.6

1.15

132

629

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

1048

8902

1.88

18.46

5.5

4.6

mmol/mol

37.5

38.5

2.75

981

8404

(40768797) Stomach Pathology biopsy report

230

1261

2.00

18.40

1.2

—

(3031040) Bacteria [#/volume] in Urine by Automated count

837

6671

1.70

18.36

5.2

3.8

e6/l

134.5

985.3

1.10

(3000991) Gas panel - Venous blood

148

686

2.30

18.23

9.8

9.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

243

1367

1.95

18.03

2.7

3.7

mmol/l

0.8

0.49

214

1288

(3014111) Lactate [Moles/volume] in Serum or Plasma

150

712

2.25

17.45

7.1

7.9

mmol/l

1.5

1.3

0.90

141

682

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

1121

9788

2.00

17.44

14.9

9.6

ml/min/173m2

92.3

91.6

0.37

900

7872

(3023323) Follitropin [Units/volume] in Serum or Plasma

157

760

2.21

17.41

1.5

1.4

iu/l

25.0

23.2

0.27

118

631

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

164

3.59

17.04

1.3

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

164

3.59

17.04

1.3

1.2

—

(3002385) Erythrocyte distribution width [Ratio]

1087

9421

1.90

16.90

21.5

13.3

13.4

0.32

1070

9222

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

132

603

2.32

16.79

1.7

1.6

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

356

2302

1.75

16.75

1.9

mg/l

0.8

1.0

1.24

248

1675

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

1242

11340

2.81

16.66

12.0

8.8

u/l

27.2

26.6

0.30

1208

11004

(3037467) Urinalysis macro (dipstick) panel - Urine

870

7097

1.67

16.57

5.0

3.8

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

224

1262

1.93

16.44

1.8

2.4

29.0

29.5

0.89

216

1226

(3021387) Prolactin [Units/volume] in Serum or Plasma

139

656

2.25

16.37

1.7

1.6

mu/l

364.3

315.9

0.42

115

588

(3032080) INR in Blood by Coagulation assay

455

3182

1.66

15.84

7.4

6.8

inr

1.1

1.15

154

1043

(3003458) Phosphate [Moles/volume] in Serum or Plasma

197

1079

1.97

15.66

6.2

6.1

mmol/l

1.1

0.12

177

1021

(4198724)

4.56

15.48

3.1

2.0

—

(3003327) Ova and parasites identified in Stool by Light microscopy

100

419

2.50

15.39

2.1

1.8

—

(3023368) Bacteria identified in Blood by Culture

328

2117

1.73

15.34

5.3

4.0

—

(3023410) Appearance of Cerebral spinal fluid

105

4.10

15.31

1.2

1.9

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

424

2937

1.66

15.19

2.9

2.4

u/l

60.7

55.8

0.40

390

2734

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

225

3.04

15.06

1.2

1.7

e6/l

326.8

605.8

0.23

182

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

225

3.04

15.06

1.2

1.6

e6/l

5.0

11.1

0.69

175

(3011397) Hemoglobin [Presence] in Urine by Test strip

342

2257

1.70

14.66

3.3

3.2

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

257

1569

1.79

14.50

2.6

2.0

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

1190

10778

2.13

14.30

16.9

11.1

mg/l

18.9

21.0

1.66

933

8248

(3013139) Helicobacter pylori Ag [Presence] in Stool

139

698

2.11

13.97

1.2

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

276

1737

1.75

13.97

1.8

1.6

pmol/l

52586648.2

33796721.9

0.14

232

1512

(36660697) Celiac disease serology panel - Serum

174

954

1.95

13.71

1.3

1.2

—

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

5.77

13.70

2.2

4.7

umol/l

122.4

145.7

0.15

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

101

450

2.35

13.59

6.4

3.8

mmol/l

24.1

0.01

412

(3019150) Specific gravity of Urine by Refractometry

339

2271

1.66

13.58

3.7

3.4

kg/l

1.0

1.79

292

(3023183) Ammonium ion [Moles/volume] in Plasma

176

3.16

13.31

1.9

3.6

umol/l

31.5

35.3

0.74

156

(46235355) HIV 1 and 2 tests - Meaningful Use set

458

3319

1.58

13.26

2.6

2.0

—

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

377

2613

1.62

13.13

3.2

2.3

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

213

1269

1.81

12.93

2.4

1.9

—

(3042517) Benzodiazepines panel - Urine

10.87

12.87

1.6

1.5

—

(40761511) CBC panel - Blood by Automated count

1237

11470

2.39

12.47

14.3

10.1

—

(40768804) Tissue Pathology biopsy report

523

3952

1.54

12.36

2.1

1.9

—

(3021601) Nitrite [Presence] in Urine by Test strip

651

5161

1.52

12.26

5.3

4.3

estimate

0.0

0.41

131

1037

(3016018) Differential panel - Cerebral spinal fluid

100

3.78

12.16

1.1

1.6

—

(3035350) Ketones [Presence] in Urine by Test strip

649

5152

1.51

12.08

3.8

3.1

estimate

0.0

0.50

122

1004

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

284

1867

1.67

12.07

1.4

1.3

iu/ml

21.1

28.1

0.38

590

(3026008) Bacteria identified in Urine by Culture

380

2699

1.57

11.72

3.5

2.5

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

157

886

1.88

11.28

2.1

1.7

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

158

902

1.85

10.94

2.1

1.8

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

473

2.16

10.90

1.4

1.5

u/l

10.8

10.0

0.20

374

(3009261) Glucose [Presence] in Urine by Test strip

647

5202

1.48

10.89

3.9

3.2

estimate

0.0

0.80

127

999

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

341

2397

1.57

10.87

2.9

2.2

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

269

1795

1.63

10.65

2.8

3.2

ng/l

1003.3

969.8

0.05

215

1459

(3044290) Cell count panel - Cerebral spinal fluid

206

2.74

10.64

1.1

1.7

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

265

1767

1.63

10.51

1.4

1.3

u/ml

16.3

11.4

0.39

733

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

115

600

2.00

10.40

4.4

3.9

ng/l

105.9

76.4

1.06

546

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

344

2.32

10.32

2.1

1.6

nmol/l

44.3

40.0

0.66

336

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

121

649

1.95

10.11

2.0

1.8

—

(3024928) Oxygen saturation in Venous blood

178

2.82

10.05

3.9

3.0

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

280

2.43

9.94

1.9

1.6

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

450

2.12

9.90

3.3

g/l

132.2

130.9

0.24

442

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

409

3051

1.49

9.73

2.0

1.7

—

(3007853) Bacteria identified in Skin by Aerobe culture

187

1162

1.71

9.67

2.0

1.6

—

(3022145) Colonoscopy Study observation

171

1039

1.74

9.59

1.4

1.3

—

(3027945) Reticulocytes/100 erythrocytes in Blood

141

813

1.82

9.43

2.5

3.3

1.8

1.7

0.43

126

732

(3009542) Hematocrit [Volume Fraction] of Blood

1148

10553

1.71

9.26

19.4

11.6

40.7

40.4

0.67

911

8519

(3003181) Sodium [Moles/volume] in Urine

110

3.24

9.22

1.7

1.4

mmol/l

55.3

71.7

1.50

(3035637) Corticotropin [Mass/volume] in Plasma

121

3.12

9.14

1.4

1.6

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

413

3122

1.47

9.08

4.0

3.0

ng/l

55.7

37.3

0.36

217

1725

(3017143) Hepatitis C virus Ab [Presence] in Serum

254

1732

1.58

9.06

2.0

1.6

—

(3005322) IgE [Units/volume] in Serum or Plasma

136

788

1.81

8.95

1.4

1.3

u/ml

237.6

240.4

0.01

129

730

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

119

663

1.87

8.88

3.8

3.5

mmol/l

1.2

1.72

576

(42529406) Shigella sp [Presence] in Stool by Culture

327

2.21

8.48

1.3

1.2

—

(3025941) Bacteria identified in Stool by Culture

117

661

1.85

8.36

1.4

1.2

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

323

2.20

8.32

1.3

1.2

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

1120

10294

1.60

8.27

4.6

4.0

mmol/l

2.9

0.12

1040

9680

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

134

793

1.77

8.22

2.5

2.4

g/l

0.2

0.51

116

745

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

128

748

1.79

8.19

1.0

1.1

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

456

2.00

8.14

1.5

1.3

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

196

1293

1.61

7.98

2.2

1.8

—

(3037522) Nuclear Ab [Titer] in Serum

223

1524

1.56

7.80

1.6

1.3

titre

356.5

508.6

1.38

305

(3023520) Reticulocytes [#/volume] in Blood

100

550

1.89

7.77

2.3

2.9

e9/l

73.9

72.2

0.15

403

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

429

2.00

7.74

1.9

1.6

—

(3051611) Lipemic interference index of Serum or Plasma

3.47

7.69

3.5

3.3

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

295

2.19

7.61

1.3

1.2

—

(3052851) Hemolysis interference index of Serum or Plasma

257

2.27

7.54

3.5

3.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

1105

10180

1.54

7.47

4.2

3.7

mmol/l

4.7

0.73

1029

9656

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

153

966

1.66

7.41

1.3

1.2

iu/ml

101.9

151.2

1.26

372

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

322

2.11

7.20

1.3

1.1

—

(3020630) Protein [Mass/volume] in Serum or Plasma

537

1.85

7.10

2.0

2.5

g/l

67.2

67.3

0.03

498

(3007461) Platelets [#/volume] in Blood

1278

12303

2.54

6.94

24.8

16.1

e9/l

258.7

259.1

0.08

1251

12039

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

209

2.35

6.90

1.2

—

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

255

2.21

6.83

1.6

2.3

ug/l

850.5

479.1

0.24

235

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

1097

10138

1.50

6.81

4.1

3.7

mmol/l

1.4

1.5

5.14

1016

9573

(3024731) MCV [Entitic volume]

1278

12318

2.49

6.64

24.7

16.0

90.2

90.0

1.09

1264

12182

(3035941) MCH [Entitic mass]

1278

12319

2.49

6.63

24.7

16.0

30.1

0.35

1264

12182

(3026361) Erythrocytes [#/volume] in Blood

1278

12320

2.48

6.61

24.8

16.0

e12/l

4.5

4.6

0.94

1249

12041

(3010813) Leukocytes [#/volume] in Blood

1278

12324

2.47

6.53

24.8

16.1

e9/l

6.8

6.7

1.77

1247

12038

(3000963) Hemoglobin [Mass/volume] in Blood

1278

12329

2.45

6.43

25.0

16.1

g/l

136.2

136.5

0.43

1262

12190

(3021879) Hepatitis B virus core Ab [Presence] in Serum

165

1099

1.57

6.42

1.6

1.5

—

(3023511) Choriogonadotropin [Units/volume] in Urine

482

1.84

6.34

1.5

1.3

—

(3012501) Base excess in Blood by calculation

188

2.33

6.15

4.6

3.4

mmol/l

2.4

0.01

113

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

509

1.80

6.15

2.2

2.8

ng/l

151.6

144.4

0.06

449

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

436

1.86

6.12

1.7

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

195

2.30

6.11

2.7

4.5

u/ml

0.3

0.4

0.20

100

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

189

2.32

6.08

1.1

—

(3003338) MCHC [Mass/volume]

1066

9852

1.44

6.08

22.1

13.6

g/l

333.4

333.3

0.14

1057

9777

(3008295) Osmolality of Serum or Plasma

2.96

6.02

1.3

1.5

mosm/kgh2o

280.6

284.5

0.30

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

257

2.11

5.92

1.9

1.5

nmol/l

0.6

0.4

0.30

211

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

2.93

5.91

1.1

—

(3026389) Candida sp identified in Specimen by Organism specific culture

130

2.58

5.90

1.3

—

(3005719) IgG [Mass/volume] in Serum or Plasma

124

792

1.62

5.75

2.8

2.7

g/l

10.7

10.4

0.36

109

721

(3009445) Proteinase 3 Ab [Units/volume] in Serum

366

1.90

5.70

1.5

u/ml

—

8.8

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

133

866

1.60

5.70

4.2

2.8

—

(3044640) Blood type and Crossmatch panel - Blood

385

3077

1.36

5.65

2.1

2.2

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

4.84

5.50

1.2

1.0

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

206

2.18

5.40

1.1

—

(1616796) Gas panel - Central venous blood

181

2.25

5.33

4.2

3.3

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

269

2.01

5.28

1.4

1.5

ug/g

326.6

298.9

0.34

148

(3003396) Base excess in Arterial blood by calculation

125

818

1.58

5.26

8.3

8.9

mmol/l

0.8

1.0

0.12

104

644

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

314

1.92

5.14

2.0

3.3

174.8

171.4

0.10

302

(3013512) EKG study

296

2300

1.37

5.14

3.8

3.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

178

2.23

5.10

1.4

1.8

g/l

0.8

0.01

133

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

1048

9740

1.38

5.08

3.7

3.4

mmol/l

1.4

1.3

3.27

973

9188

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

302

1.93

5.04

1.4

2.2

g/l

1.5

1.4

0.17

264

(21494755) Public health laboratory ask at order entry panel

101

1550

0.62

5.01

1.2

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

435

1.77

4.99

1.9

2.1

—

(4062490)

111

2.56

4.98

1.3

1.4

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

2.89

4.94

1.2

1.3

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

4.09

4.90

1.5

2.1

umol/l

10.7

16.6

2.18

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

2.95

4.88

5.1

4.0

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

517

1.69

4.79

1.6

1.4

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

139

2.33

4.71

1.3

1.4

—

(3010421) pH of Blood

226

2.03

4.65

4.5

3.2

7.4

0.03

187

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

233

2.01

4.64

1.5

1.4

u/ml

109.9

105.3

—

(3020682) Albumin/Creatinine [Ratio] in Urine

293

2308

1.35

4.62

3.7

4.1

mg/mmol

9.5

10.8

0.14

181

1505

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

132

902

1.52

4.59

2.4

2.2

u/l

3742.3

4357.7

0.12

341

(3024139) IgG subclass 3 [Mass/volume] in Serum

110

2.49

4.56

1.2

1.3

g/l

0.3

0.4

0.59

(3027135) IgG subclass 1 [Mass/volume] in Serum

110

2.49

4.56

1.2

1.3

g/l

5.9

6.5

0.40

(3028192) IgG subclass 2 [Mass/volume] in Serum

110

2.49

4.56

1.2

1.3

g/l

3.2

2.7

0.86

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

249

1.96

4.54

1.6

1.4

—

(3025130) Human papilloma virus identified in Specimen

204

2.04

4.36

1.8

1.7

—

(3012516) Albumin [Mass/volume] in Urine

279

2201

1.34

4.33

3.2

3.4

mg/l

80.4

304.7

1.98

175

1441

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

966

8942

1.31

4.28

4.2

3.6

—

(3036489) Thrombin time

387

1.74

4.27

1.8

2.8

20.9

21.2

0.34

340

(4010399)

639

1.58

4.22

1.4

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

2.69

4.17

1.1

u/l

1.0

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1301

0.63

4.16

1.6

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

122

841

1.50

4.09

2.1

4.5

u/l

210.5

245.0

2.04

113

796

(3006653) Thiamine [Moles/volume] in Blood

3.22

4.06

2.1

1.6

nmol/l

141.5

148.8

0.19

(3051651) Icteric interference index of Serum or Plasma

2.96

4.02

4.2

3.5

—

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

240

1.91

3.96

1.4

1.9

g/l

3.1

0.01

197

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

233

1.92

3.96

1.3

1.8

g/l

9.9

10.4

0.52

206

(40767503) Oxygen content in Capillary blood by calculation

164

2.10

3.94

4.3

2.3

17.3

16.7

0.54

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

429

1.67

3.88

1.7

2.2

u/l

40.0

39.1

0.14

390

(3029937) Albumin [Presence] in Urine by Test strip

334

2740

1.29

3.88

4.4

3.5

estimate

0.0

0.06

120

1008

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

7.31

3.86

9.6

6.8

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.99

3.85

1.1

1.2

—

(3002256) Pathology report gross observation

164

1214

1.40

3.78

1.2

—

(3028026) IgM [Mass/volume] in Serum or Plasma

625

1.54

3.74

2.1

1.7

g/l

1.4

1.3

0.14

576

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

2.49

3.64

1.1

—

(3050129) First trimester maternal screen panel - Serum or Plasma

741

0.55

3.61

1.6

1.4

—

(3040151) Glucose [Moles/volume] in Capillary blood

2.42

3.57

10.3

7.8

mmol/l

7.8

6.7

0.61

(3021901) Oxygen saturation in Capillary blood

137

2.14

3.57

3.9

2.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

379

1.67

3.50

1.6

1.4

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1.82

3.49

1.4

1.8

—

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1.82

3.49

1.4

1.8

g/l

3.6

3.8

1.09

192

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

251

1.82

3.49

1.4

1.8

g/l

7.1

7.4

0.52

205

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

3.57

3.48

1.4

1.1

—

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

113

2.24

3.43

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

2.41

3.40

1.3

1.4

pmol/l

117.4

57.6

—

(4027681)

2.46

3.39

1.2

1.3

—

(3022217) INR in Platelet poor plasma by Coagulation assay

115

816

1.45

3.37

15.4

16.1

inr

1.0

1.2

2.25

124

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

226

1792

1.32

3.35

3.9

4.0

ug/l

1.6

2.0

1.10

201

1629

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

3.26

3.34

1.1

2.3

—

(3004716) Salmonella sp identified in Stool by Organism specific culture

111

784

1.45

3.33

1.5

1.4

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

170

1.97

3.26

3.2

3.4

mg/l

43.2

48.1

0.17

137

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

170

1.97

3.26

3.2

3.4

mg/l

50.3

30.0

0.62

136

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

2.40

3.23

1.6

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

2.88

3.19

1.9

1.3

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

566

1.52

3.18

2.6

2.3

ug/l

5.3

7.0

0.52

512

(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid

117

2.16

3.17

1.1

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

392

1.61

3.10

2.5

2.2

—

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

353

1.64

3.09

1.8

3.0

95.2

92.9

0.38

328

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

465

4058

1.23

3.06

4.1

3.2

—

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

113

2.14

3.01

1.2

1.3

—

(3000492) Spirometry study

146

1104

1.36

2.98

1.4

1.3

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

242

1.76

2.97

1.2

1.3

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

540

4796

1.21

2.96

3.5

3.9

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

121

2.09

2.94

1.2

1.1

—

(4094501)

206

1.82

2.93

1.1

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

2.23

2.90

1.6

1.2

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

2.23

2.90

1.1

1.0

—

(3006184) Hemoglobin [Mass/volume] in Capillary blood

185

1.86

2.89

2.9

2.2

g/l

137.7

132.5

0.94

140

(1761868) Lipid panel - Serum or Plasma

368

4256

0.81

2.89

2.8

2.4

—

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

923

0.64

2.88

1.4

1.3

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

2.21

2.84

1.6

1.2

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

123

2.05

2.82

1.1

—

(3015235) Bicarbonate [Moles/volume] in Capillary blood

216

1.78

2.82

4.8

2.6

mmol/l

23.9

24.7

0.42

191

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1152

0.68

2.82

1.5

—

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

3.07

2.81

1.0

—

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

339

1.62

2.80

1.8

2.1

—

(3011648) Oxygen content in Venous blood

2.41

2.80

3.6

2.6

13.1

11.6

1.06

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

4.46

2.79

1.3

1.2

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

110

2.11

2.79

1.2

1.3

nmol/l

—

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

3.93

2.77

2.2

1.6

—

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

310

1.64

2.73

1.9

3.4

g/l

3.7

3.6

0.15

295

(3042936) Bacteria identified in Isolate by Culture

163

1278

1.31

2.63

2.3

2.0

—

(3008898) HLA-B27 [Presence]

524

1.48

2.63

1.1

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

592

1.45

2.60

1.3

miu/ml

229.6

236.9

0.07

304

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.91

2.58

1.4

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

2.24

2.54

1.1

2.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

3.35

2.39

3.9

2.1

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

190

1.76

2.39

1.3

1.2

u/ml

1.9

4.4

1.01

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

260

1.64

2.35

1.6

2.5

mg/l

13.3

10.7

0.78

240

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

458

0.56

2.31

1.4

1.5

—

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

705

1.37

2.23

2.1

2.3

ml/min/173m2

73.8

75.9

0.18

280

(3018405) Lactate [Moles/volume] in Arterial blood

264

1.61

2.22

3.3

3.8

mmol/l

1.6

1.4

0.49

259

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

2.63

2.18

2.1

1.3

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

188

1.72

2.18

1.3

u/ml

3.4

5.0

0.54

(3048929) Epstein Barr virus Ab [Presence] in Serum

554

1.41

2.17

1.3

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

131

1.85

2.09

1.2

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

542

1.41

2.07

3.7

3.5

kpa

5.2

5.1

0.20

506

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

2.92

2.07

1.1

1.2

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

2.09

2.07

1.6

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

5.01

2.07

1.4

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

302

1.54

2.05

1.8

iu/l

2.1

5.8

—

109

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

2.19

2.05

1.1

1.2

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

518

1.41

2.05

3.6

3.5

mmol/l

2.1

1.5

0.98

369

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

174

1428

1.25

1.99

3.5

3.6

21.3

0.00

569

(40761536) Microorganisms panel - Urine sediment

120

940

1.30

1.99

4.8

3.3

—

(3009343) pH of Capillary blood

538

1.40

1.99

3.7

3.5

7.4

0.47

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.29

1.98

3.0

3.6

u/ml

608.0

728.6

0.23

(40760892) CBC W Ordered Manual Differential panel - Blood

301

2620

1.19

1.93

4.2

4.4

—

(3019060) Gas panel - Arterial blood

432

1.43

1.91

4.4

5.5

—

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

515

0.63

1.87

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

385

1.45

1.84

8.3

12.2

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

2.51

1.83

1.7

1.1

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

130

1042

1.27

1.83

2.4

2.6

ug/l

0.5

0.7

5.58

599

(3007463) Buprenorphine [Presence] in Urine

4.18

1.82

5.8

2.3

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

4.18

1.82

5.6

2.5

mmol/l

4.9

8.1

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

207

1.61

1.81

1.1

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

2.35

1.78

1.6

1.5

—

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

102

1.88

1.76

2.1

1.7

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

270

2347

1.19

1.75

1.6

1.5

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

2.68

1.72

1.0

1.6

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

358

1.44

1.70

1.3

1.2

—

(40768446) Kidney Pathology biopsy report

2.39

1.68

2.1

1.6

—

(3042733) HLA Ab [Presence] in Serum

2.59

1.66

8.5

3.1

—

(3026493) Urate [Moles/volume] in Serum or Plasma

259

2255

1.19

1.65

2.2

2.4

umol/l

1634.8

4724.7

1.29

226

2007

(3020891) Body temperature

287

1.48

1.61

4.9

4.7

—

(40760888) Immunoglobulin light chains.free panel - Serum

128

1.73

1.61

4.0

3.9

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

1.88

1.61

1.1

1.0

—

(3034770) Mitochondria Ab [Titer] in Serum

305

1.46

1.58

1.2

1.3

—

796.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

199

1.57

1.58

1.1

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

2.12

1.55

2.0

2.8

ug/l

18.6

593.1

0.69

(40768443) Skin Pathology biopsy report

358

1.41

1.52

1.4

1.2

—

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1045

0.77

1.50

3.3

3.6

30.5

31.7

0.42

752

(3025018) Bordetella pertussis Ab [Titer] in Serum

1.91

1.49

1.2

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

210

1.54

1.49

1.3

1.2

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

2.08

1.49

1.0

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

132

1.68

1.46

1.2

1.1

g/l

1.7

1.5

1.13

116

(44813793)

1.85

1.46

1.0

—

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

362

1.40

1.44

1.1

u/ml

1.2

5.1

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

264

2338

1.16

1.37

2.2

2.1

—

(3039443) Prostate specific Ag panel - Serum or Plasma

162

0.49

1.36

1.4

1.6

—

(3033799) Differential panel - Peritoneal fluid

2.95

1.36

2.0

1.8

—

(3022689) Creatine [Moles/volume] in Urine

2.95

1.36

1.0

1.6

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

2.95

1.36

4.2

5.1

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

2.95

1.36

1.0

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

123

1018

1.23

1.36

7.0

5.5

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

297

2656

1.15

1.36

2.0

1.7

—

(3037756) Immunofixation for Serum or Plasma

112

1.71

1.35

1.6

—

(3042631) Mycobacterium sp identified in Specimen

1.79

1.33

2.1

3.0

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

555

0.71

1.32

1.6

—

(3034274) Bile acid [Moles/volume] in Serum --fasting

250

1.45

1.32

2.4

umol/l

5.1

5.7

0.20

185

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.00

1.31

0.0

2.3

—

88593.6

—

(3005011) Chlamydia sp Ab [Titer] in Serum

2.51

1.30

1.5

1.3

—

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

2.36

1.29

1.0

1.1

—

33.2

—

(3012441) Differential panel - Pleural fluid

2.09

1.28

1.8

1.4

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

346

1.37

1.26

1.1

—

(3044242) Glucose [Moles/volume] in Arterial blood

2.01

1.23

1.0

3.4

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

1.91

1.23

2.7

1.7

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

2.05

1.22

1.1

u/ml

0.3

1.6

—

(3049717) Cytology report of Urine Cyto stain

213

1.47

1.21

2.2

2.4

—

(3041096) Erythrocytes [Presence] in Urine by Automated

335

3045

1.13

1.20

3.8

2.7

—

(1761482) Bacteria [#/volume] in Urine by Culture

189

1.49

1.19

4.9

3.5

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.75

1.19

2.5

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

206

1.47

1.18

1.1

1.0

u/ml

1.7

2.3

0.24

102

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

133

1.59

1.17

2.3

1.6

—

(3017732) Neutrophils [#/volume] in Blood

734

1.24

1.16

1.8

2.4

e9/l

3.9

4.1

0.39

617

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

283

1.39

1.15

1.5

1.3

u/ml

190.6

222.9

0.55

174

(3041354) Potassium [Moles/volume] in Venous blood

1.73

1.15

2.5

2.4

mmol/l

4.0

0.01

(3035285) Chloride [Moles/volume] in Venous blood

1.73

1.15

2.5

2.4

mmol/l

105.6

105.4

0.04

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

224

1.44

1.15

1.8

2.6

nmol/l

0.7

0.9

0.82

193

(3020874) Milk IgE Ab [Units/volume] in Serum

1.69

1.14

1.1

u/ml

0.2

2.5

—

(3037121) Protein [Mass/volume] in Urine

327

1.36

1.13

2.5

4.0

g/l

0.2

0.3

2.03

151

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

2.34

1.12

1.7

3.2

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

217

1.44

1.12

2.6

2.8

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

143

1.55

1.12

1.5

1.4

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

1.79

1.11

1.2

2.5

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

218

1.43

1.09

1.1

1.3

—

(3017509) Phencyclidine [Presence] in Urine

2.39

1.09

4.2

1.1

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

2.39

1.09

1.2

1.0

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

194

1.45

1.07

1.2

1.1

—

(3032773) Endomysium IgG Ab [Titer] in Serum

129

1.56

1.06

1.1

—

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

2.28

1.03

1.4

1.3

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

1.92

1.02

1.0

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

163

1.48

1.02

2.4

3.2

—

(3000093) Morphology [Interpretation] in Blood Narrative

1.77

1.00

1.0

1.2

—

(3023419) Bacteria identified in Sputum by Culture

1.62

1.00

2.8

3.6

—

(3044007) Cell count panel - Peritoneal fluid

2.18

0.98

2.6

2.0

—

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

132

1.52

0.97

1.2

—

(3003434) Protein [Mass/volume] in Pleural fluid

1.86

0.96

1.7

1.4

g/l

31.6

33.2

—

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

1.77

0.94

1.3

1.2

—

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

2.23

0.93

1.3

1.1

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

2.23

0.93

1.2

1.3

—

(3000330) Specific gravity of Urine by Test strip

410

1.28

0.93

3.6

2.7

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

279

0.68

0.91

1.2

—

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

297

1.32

0.90

1.4

1.2

—

(4268621)

127

1.50

0.88

2.4

2.3

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

194

1.40

0.88

1.0

1.2

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

150

1322

1.15

0.87

1.9

—

(4306422)

178

1.41

0.86

1.2

—

(3010838) Calcium [Moles/time] in 24 hour Urine

1.78

0.84

1.4

1.5

—

8.9

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

154

1.44

0.83

2.3

1.8

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

214

1.36

0.83

1.3

1.2

—

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

0.00

0.79

0.0

1.3

—

(3036670) Protein [Mass/volume] in Synovial fluid

0.00

0.79

0.0

1.1

—

39.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

0.00

0.78

0.0

1.0

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

561

0.80

0.78

1.8

1.9

—

(40768806) Pleura Pathology biopsy report

1.70

0.75

1.6

—

(21494890) Protein electrophoresis panel - 24 hour Urine

1.67

0.74

1.1

2.4

—

(3044941) Cell count panel - Synovial fluid

133

1.43

0.73

1.6

1.4

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

334

0.74

0.73

2.4

1.9

—

(3045788) Cell count panel - Pleural fluid

1.85

0.73

2.1

1.5

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

1.80

0.72

1.4

1.2

—

97.6

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

642

0.82

0.72

1.5

—

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

1.75

0.71

1.4

1.1

—

93.2

—

(3024263) Appearance of Synovial fluid

1.75

0.71

1.4

1.9

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

675

1.18

0.71

2.7

4.2

ug/l

3.9

24.6

0.98

520

(3006576) Bicarbonate [Moles/volume] in Blood

1.93

0.70

1.8

6.5

mmol/l

25.5

24.6

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

143

1.40

0.70

1.9

1.5

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

101

1.49

0.70

1.3

1.7

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

101

1.49

0.70

1.0

1.1

u/ml

0.2

6.1

—

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

1.85

0.68

1.0

1.2

—

(3034426) Prothrombin time (PT)

1.67

0.68

1.0

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

1.67

0.68

1.0

1.4

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

1.67

0.68

1.0

1.4

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

0.54

0.67

2.8

3.9

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

1.63

0.67

3.7

1.7

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

1.63

0.67

3.7

1.7

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.52

0.66

1.1

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.52

0.66

1.1

1.2

—

(3000060) B lymphocytes [#/volume] in Blood

1.59

0.65

1.4

2.3

e6/l

237.1

223.5

—

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

112

1.43

0.63

1.1

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.50

0.63

1.1

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

223

0.71

0.63

1.4

1.3

—

(3000034) Microalbumin [Mass/volume] in Urine

1.55

0.62

1.8

2.8

mg/l

94.1

33.3

—

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

1.64

0.62

3.4

1.6

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

585

0.83

0.60

1.4

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.60

0.0

1.5

—

7.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

584

0.83

0.59

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

584

0.83

0.59

1.4

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.59

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.00

0.59

0.0

1.1

—

(4034850)

310

0.77

0.59

4.4

7.6

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

219

1.28

0.59

1.5

—

(3003888) Timothy IgE Ab [Units/volume] in Serum

309

1.24

0.58

1.2

1.1

u/ml

7.3

0.00

170

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

582

0.84

0.58

1.4

—

(3017569) Oxygen content in Arterial blood

1.72

0.57

1.0

4.1

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

247

1.26

0.57

2.3

1.5

—

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

1.51

0.56

1.5

1.3

—

(3028433) Virus identified in Specimen by Culture

1.62

0.55

1.0

1.3

—

(3020876) Protein [Mass/time] in 24 hour Urine

1.54

0.55

1.9

2.1

—

1.9

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

267

1.24

0.54

2.1

1.8

—

(3003740) Influenza virus B Ag [Presence] in Specimen

272

0.77

0.54

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

272

0.77

0.54

1.0

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

1.49

0.53

1.0

1.1

—

(3025159) Blasts/100 leukocytes in Blood

729

1.13

0.48

3.9

4.6

0.0

0.1

1.18

165

(3042111) Morphology [Interpretation] in Bone marrow Narrative

111

0.63

0.48

1.1

1.8

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

242

0.78

0.45

1.1

1.0

u/ml

0.2

5.4

—

(3041806) Other cells [#/volume] in Blood by Manual count

112

1.34

0.44

1.2

1.7

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.40

0.44

1.1

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.40

0.44

1.1

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.40

0.44

1.1

1.2

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

202

1.24

0.43

1.0

1.1

—

(3021788) Differential panel - Synovial fluid

148

1.29

0.43

1.7

1.6

—

(3030905) Polymorphonuclear cells [#/volume] in Blood

212

1.23

0.42

2.4

3.7

e9/l

4.3

4.1

0.23

212

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

332

1.18

0.42

1.2

1.1

u/ml

1.2

2.1

0.32

137

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

379

1.17

0.41

1.5

1.6

iu/ml

0.1

0.07

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

0.00

0.41

0.0

1.8

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

0.00

0.41

0.0

1.4

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

0.00

0.41

0.0

7.6

—

0.4

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

0.00

0.40

0.0

1.1

—

(3009871) Measles virus Ab [Titer] in Serum

1.47

0.40

1.8

1.7

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.40

0.0

2.7

—

0.7

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

303

0.82

0.40

2.3

1.8

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

1.43

0.39

1.0

1.4

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.43

0.39

1.2

1.3

—

(3049714) Procollagen type I.N-terminal propeptide [Mass/volume] in Serum

1.43

0.39

2.6

2.4

ug/l

43.4

66.1

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

1.43

0.39

1.0

1.4

—

(3029075) Extractable nuclear Ab panel - Serum

1.43

0.39

1.2

1.1

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.41

0.39

1.0

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.41

0.39

1.0

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.41

0.39

1.5

2.8

—

(3000012) Reticulocyte production index

1.39

0.38

1.2

1.7

—

(3024932) HLA-DR beta [Type]

1.39

0.38

1.0

1.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

225

1.20

0.37

2.0

1.7

—

(3024471) HLA-A [Type]

1.35

0.37

1.0

—

(3045414) Leukocytes [Presence] in Urine

450

1.14

0.36

1.5

1.7

—

(3032035) Polymorphonuclear cells/100 leukocytes in Blood

217

1.20

0.35

2.4

3.9

58.4

56.5

0.39

217

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

245

1.19

0.35

1.7

1.4

u/l

31.1

21.8

0.59

204

(3043238) Trisomy 21 risk [Likelihood] in Fetus

478

0.87

0.34

1.5

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

136

1.25

0.33

1.6

1.5

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

256

1.18

0.33

3.5

3.2

u/ml

13.4

714.8

0.72

220

(3015183) Erythrocyte sedimentation rate

0.70

0.33

1.7

1.2

—

(40768800) Prostate Pathology biopsy report

0.68

0.33

1.3

1.2

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

294

1.16

0.32

1.2

1.1

u/ml

0.9

1.4

0.45

129

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

1.33

0.32

1.5

1.3

—

(3045424) Erythrocytes [Presence] in Urine

183

1.21

0.32

1.3

1.4

—

(40761535) Cells panel - Urine sediment

695

1.10

0.31

3.8

3.2

—

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

174

1.21

0.31

1.2

1.7

—

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

0.71

0.31

2.0

1.3

—

(3029080) Hemoglobin [Entitic mass] in Reticulocytes

1.31

0.30

1.0

1.7

32.1

32.5

0.07

(21494815) CD4 cells/100 lymphocytes in Specimen

1.29

0.30

1.4

2.2

—

43.7

—

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

157

1.21

0.29

2.3

1.5

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

1.23

0.29

1.0

1.1

miu/ml

2175.7

1770.5

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

223

1.17

0.28

2.1

1.7

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

112

1.25

0.28

2.6

1.5

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

1.30

0.28

1.2

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

1.30

0.28

1.5

1.9

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

131

1.22

0.27

1.4

1.2

u/l

13.0

28.4

0.93

109

(3019225) pH of Specimen

770

1.08

0.27

4.5

3.5

—

(4146454)

0.70

0.26

3.4

2.9

—

(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay

0.69

0.26

1.4

1.2

—

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

0.68

0.26

1.2

—

77.5

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

0.68

0.26

1.2

—

38.4

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

1.23

0.25

1.7

2.2

—

(3022313) Gas panel - Capillary blood

397

1.11

0.25

3.8

3.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

465

0.90

0.24

1.5

1.4

—

(40768441) Liver Pathology biopsy report

1.28

0.24

1.3

1.4

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.74

0.24

2.2

1.7

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.74

0.24

2.2

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.74

0.24

2.2

1.7

—

(3005033) Fetal Nuchal fold Thickness US

464

0.90

0.24

1.5

1.4

—

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

1.25

0.22

1.2

1.1

—

(3022621) pH of Urine by Test strip

603

1.08

0.22

3.6

2.2

—

(3021440) Promyelocytes/100 leukocytes in Blood

768

1.07

0.22

4.0

4.5

0.2

0.1

0.10

199

(3004616) Nuclear Ab [Presence] in Serum

116

1.21

0.22

1.5

1.3

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

0.00

0.21

0.0

2.0

—

(3051339) Copper [Moles/volume] in Blood

0.00

0.21

0.0

1.1

—

16.1

—

(3019768) Coxiella burnetii Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

0.00

0.21

0.0

1.0

—

56.4

—

(3050794) Legionella sp Ab [Presence] in Serum

0.00

0.21

0.0

1.1

—

(3010937) Rubella virus Ab [Presence] in Serum

0.00

0.21

0.0

1.2

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

0.00

0.21

0.0

2.5

—

(3005570) Glucose [Moles/volume] in Urine

108

1.21

0.20

2.5

2.3

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

113

0.80

0.20

1.4

1.6

—

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

1.23

0.20

1.0

1.2

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

146

1.17

0.19

1.3

—

(3035933) Granulocytes/100 leukocytes in Blood

1.15

0.19

1.3

2.0

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

1.24

0.18

1.3

2.6

e6/l

536.8

562.3

—

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

1.24

0.18

1.5

1.8

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

1.13

0.16

1.3

1.2

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.11

0.16

2.4

2.0

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

176

1816

0.96

0.15

1.5

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.15

0.15

1.7

1.3

—

69.1

—

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

1.14

0.15

1.3

2.6

e9/l

0.2

—

(3002179) Metamyelocytes/100 leukocytes in Blood

742

1.05

0.15

3.4

4.1

0.4

0.5

0.48

156

(4281824)

0.79

0.14

1.1

—

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

0.79

0.14

1.7

1.5

g/l

0.9

1.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

216

2106

1.03

0.14

2.1

1.7

—

(3017181) Myelocytes/100 leukocytes in Blood

805

1.05

0.13

3.9

4.4

0.6

0.9

0.68

217

(3014051) Protein [Presence] in Urine by Test strip

219

1.10

0.12

1.8

1.9

—

(3023430) Cat dander IgE Ab [Units/volume] in Serum

220

0.91

0.12

1.1

1.0

u/ml

1.5

7.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

475

0.95

0.11

1.4

1.5

—

(40768793) Breast Pathology biopsy report

231

1.08

0.10

1.2

1.3

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

173

1.10

0.10

1.1

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

290

1.07

0.10

1.1

u/ml

0.2

3.9

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.14

0.10

1.2

1.1

—

(3029396) Erythrocyte agglutination [Presence] in Blood

1.11

0.09

2.6

3.0

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.09

0.09

1.0

1.1

iu/ml

194.6

200.7

—

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

116

1.12

0.09

2.7

1.5

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

204

1.08

0.08

4.8

3.4

mg/l

21.9

25.4

0.28

130

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

136

1.10

0.08

2.5

1.5

—

(3044927) Protein electrophoresis panel - Urine

0.78

0.08

1.6

1.1

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

1.08

0.08

1.4

1.6

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

1.06

0.08

1.3

1.1

—

(3001019) Free T4 and TSH panel - Serum or Plasma

816

1.03

0.08

1.4

1.6

—

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

1.03

0.08

2.6

1.6

—

(3020491) Glucose [Moles/volume] in Blood

1.07

0.07

2.1

1.7

mmol/l

5.6

6.1

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

118

1.10

0.07

1.1

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

122

0.90

0.07

1.1

1.4

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

100

1.10

0.05

1.4

—

(3003694) ABO and Rh group [Type] in Blood

351

3483

1.01

0.05

1.6

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

160

1.06

0.04

3.1

2.5

—

(44790047)

123

1.06

0.01

1.6

1.5

—

(44790048)

123

1.06

0.01

1.6

1.5

—

(44806118)

123

1.06

0.01

1.6

1.5

—

(44790049)

123

1.06

0.01

1.6

1.5

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

194

1.03

0.00

2.5

2.4

ug/min

93.1

134.8

0.38

121

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

121

0.99

0.00

1.1

1.4

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

121

0.99

0.00

1.1

1.4

—

(4035726)

708

1.00

0.00

1.5

1.4

—

(3000475) Leukocytes [#/volume] in Synovial fluid

201

0.99

0.00

1.6

1.7

e6/l

1091.4

13383.2

—

150

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

117

1.03

0.00

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

123

0.98

0.00

1.1

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

535

1.01

0.00

1.4

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

0.91

0.00

1.3

1.5

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

0.97

0.00

1.3

2.0

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

120

1.00

0.00

1.1

1.4

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

120

1.00

0.00

1.1

1.4

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

0.00

0.0

1.0

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.0

1.4

—

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.3

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

0.00

0.0

1.0

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.0

3.9

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

0.00

0.0

1.4

—

(40760409) HLA-A [Type] by High resolution

0.00

0.0

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

3.7

—

(3018834) Bilirubin.total [Presence] in Urine by Test strip

0.00

0.0

2.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.2

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

0.00

0.0

1.0

—

(40760410) HLA-B [Type] by High resolution

0.00

0.0

1.0

—

(3013862) HLA-DP [Type]

0.00

0.0

1.0

—

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

0.00

0.0

3.6

—

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.3

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

0.00

0.0

1.2

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

0.00

0.0

1.0

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

0.00

0.0

1.0

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

0.00

0.0

1.0

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

0.0

5.4

—

(3011325) HIV 1+2 Ab [Presence] in Serum

0.00

0.0

1.0

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

0.00

0.0

1.1

—

(40768795) Lymph node Pathology biopsy report

0.99

0.00

1.0

1.1

—

(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay

0.00

0.0

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

0.00

0.0

1.0

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

0.98

0.00

2.5

2.4

umol/l

54.7

50.2

—

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

0.00

0.0

1.0

—

(36305790) Ustekinumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.3

—

3.4

—

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

0.00

0.0

1.0

—

(3003157) Bacteria [#/volume] in Mother's milk

0.00

0.0

8.0

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.91

0.00

1.0

—

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

0.00

0.0

1.8

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

0.00

0.0

2.3

—

187.3

—

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

0.00

0.0

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.7

—

(4024509)

1.01

0.00

1.4

1.3

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.91

0.00

1.6

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint F5_SLEEP_NOS and mortality.

Females

Parameter	HR [95% CI]	p-value
F5_SLEEP_NOS	1.915 [1.54, 2.39]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.021

During the follow-up period (1.1.1998 — 31.12.2019), 311 out of 4213 females with F5_SLEEP_NOS died.

Males

Parameter	HR [95% CI]	p-value
F5_SLEEP_NOS	2.307 [1.88, 2.83]	< 0.001
Birth year	0.986 [0.98, 1.0]	0.003

During the follow-up period (1.1.1998 — 31.12.2019), 416 out of 4613 males with F5_SLEEP_NOS died.

Mortality risk

Mortality risk for people of age

years, who have F5_SLEEP_NOS.

N-year risk	Females	Males
1	0.166%	0.436%
5	1.021%	2.599%
10	2.371%	6.311%
15	4.257%	11.178%
20	7.481%	18.768%

Relationships between endpoints

↥

Index endpoint: F5_SLEEP_NOS – Sleep disorders, other/unspecified

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

Extremity

rg [CI]

Extremity

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Sleep disorders, other/unspecified

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints